Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: AMPH stock price vs VLO: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at VLO's multiple
Needs VLO P/E.
Implied fair value · at AMPH's multiple
Needs AMPH P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: AMPH FY 2025 (ended Dec 31, 2025) · VLO FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 61% equity / 39% debt · EV / Revenue 1.84x · EV / EBITDA 6.20x
Capital structure 91% equity / 9% debt · EV / Revenue 0.92x · EV / EBITDA 17.34x
VLO carries the larger enterprise value at $112.67B against $1.32B; VLO trades on the lower EV / Revenue multiple (0.92x vs 1.84x); AMPH on the lower EV / EBITDA (6.20x vs 17.34x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Amphastar Pharmaceuticals, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
VALERO ENERGY CORP/TX · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.79x
0.45x
Net debt / EBITDA
Leverage against operating earnings
1.58x
0.91x
Cash and equivalents
Liquid reserves on the balance sheet
$282.81M
$4.69B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BRISTOL MYERS SQUIBB CO
AMPH vs BMY
TEVA PHARMACEUTICAL INDUSTRIES LTD
AMPH vs TEVA
Bausch Health Companies Inc.
AMPH vs BHC
PERRIGO Co plc
AMPH vs PRGO
ANI PHARMACEUTICALS INC
AMPH vs ANIP
Marathon Petroleum Corp
AMPH vs MPC
EXXON MOBIL CORP
AMPH vs XOM
CHEVRON CORP
AMPH vs CVX
PBF Energy Inc.
AMPH vs PBF
HALLIBURTON CO
AMPH vs HAL
ONEOK INC /NEW/
AMPH vs OKE
$619.71M
$10.62B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
